Clinical Trials
3 trialsNCT04910425 2025-10-21
PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer
Northwestern University
Phase 2 Withdrawn
NCT00375830 2023-12-12
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
Stanford University
Phase 2 Completed
NCT02796729 2019-01-28
CEST- Glucose Enhanced MRI for Metastatic Brain Tumours
British Columbia Cancer Agency
Phase 2 Terminated